Dr Louisa Gnatiuc
Contact information
AWARDS
The World Heart Federation Salim Yusuf Emerging Leaders Programme 2020
The European Society of Cardiology Educational Grant 2017
Research groups
- Causal associations of body composition and disease-specific mortality in contrasting populations
- A GWAS atlas of adiposity traits in Mexicans
- Polygenic risk scores for prediction of cause-specific disease and mortality risk in Mexicans
- Metabolic rate and risk of diabetes, cardiovascular and other diseases in different populations
- An atlas of metabolomic risk factors for specific diseases and mortality in Mexicans
- Risk scores for prediction of diabetes and its complications
- Novel biomarkers and risk for co-mordbidities of adiposity and diabetes in the UK Biobank
- Adiposity and risk of respiratory diseases
- The relationship between COVID-19 and cardio-metabolic health risks
- Biomarker signatures of lifestyle determinants for preventable cardio-metabolic diseases
Websites
-
Mexico City Prospective Study
Cohort Study
-
International Advisory Board
The Lancet Global Health
-
Nucleus Member, Deputy Prevention Implementation Committee
European Society of Preventive Cardiology
-
Module Lead and Lecturer in Epidemiology
University of Oxford
-
Associate Editor
Global Heart Journal
-
External Lecturer in Chronic Disease Epidemiology
London School of Hygiene and Tropical Medicine
-
Honorary Research Associate
Imperial College London, NHLI
Louisa Gnatiuc Friedrichs
BA, DLSHTM, MSc, DPhil
Senior Epidemiologist
With experience in acute medicine, epidemiology and public health in Europe, Africa, Asia and South America, Louisa is passionate about population health. Trained in epidemiology and population health at the University of Oxford and the London School of Hygiene & Tropical Medicine, her primary interests include conventional and genetic determinants of vasculo-metabolic diseases, and novel disease models. Her work focuses on the effects of adiposity, diabetes and hypertension on premature cardiometabolic mortality in the Mexico City Prospective Study, the Prospective Studies Collaboration and the UK Biobank.
Louisa is a member of the International Advisory Board for Lancet Global Health, a Nucleus Member of the European Society for Preventive Cardiology and an editor for the Global Heart Journal. She preserves a keen interest in teaching, research of under-studied populations where the burden of preventable vasculo-metabolic risk is increasing,and collaboration with multi-national research programs.
Her expertise comprises design, conduct and analysis of large multi-centric surveys, cohort studies, biobanks, and follow-up through surveillance and vital registries. Previous roles involved coordination of British, European and global epidemiological studies with Imperial College London and the Medical Research Council, advisory for the Department of Health and Pharma.
Outside work, she likes arts, photography and world cuisines.
Recent publications
Basal metabolic rate and risk for diabetes and its complications among 341,790 adults from the UK Biobank.
Journal article
Frimpong J. et al, (2026), Diabetes Res Clin Pract, 235
Kidney function and mortality in Mexico: prospective study of 130 000 adults
Journal article
Aguilar Ramirez D. et al, (2026), Kidney Medicine
Metabolomic profile of genetic liability to type 2 diabetes among 125,000 Mexican adults: a Mendelian randomisation study
Journal article
BRAGG F. et al, (2026), Diabetes Care
The effect of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134 548 individuals from the Mexico City Prospective Study.
Journal article
Berumen J. et al, (2026), Lancet Public Health, 11, e111 - e119
Validation of the European SCORE2 algorithm in one European and one Latin-American cohort studies with contrasting populations.
Journal article
Maung KK. et al, (2026), Eur Heart J Qual Care Clin Outcomes
The impact of Indigenous American genomic ancestry on type 2 diabetes in Mexico: an analysis of 134,548 individuals from the Mexico City Prospective Study
Journal article
EMBERSON J. et al, (2025), The Lancet Public Health
Prediabetes and Risk of All-Cause and Cause-Specific Mortality: A Prospective Study of 114 062 Adults in Mexico City.
Journal article
Fermín-Martínez CA. et al, (2025), J Clin Endocrinol Metab, 110, 3451 - 3460
Polygenic prediction of coronary heart disease among 130,000 Mexican adults.
Journal article
Liu T. et al, (2025), Eur J Prev Cardiol
Blood Pressure and Mortality in Mexico City: A Mendelian Randomization Study.
Journal article
Turner M. et al, (2025), Hypertension, 82, 1896 - 1905
Fibular length and vital capacity in the multinational Burden of Obstructive Lung Disease follow-up study.
Journal article
Burney PGJ. et al, (2025), Eur Respir J, 66

